Search results
Results From The WOW.Com Content Network
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
E. Environmental Toxicology and Pharmacology; European Journal of Clinical Pharmacology; European Journal of Pharmaceutical Sciences; European Journal of Pharmaceutics and Biopharmaceutics
Therapeutic Innovation & Regulatory Science is a bimonthly peer-reviewed medical journal that covers research and developments concerning pharmaceuticals and the development and use of medical products. It is published by Springer Nature on behalf of the Drug Information Association.
Pharmaceutical innovations are currently guided by a patent system, [1] the patent system protects the innovator of medicines for a period of time. The patent system does not currently stimulate innovation or pricing that provides access to medicine for those who need it the most, It provides for profitable innovation. [ 2 ]
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales.
Pharmaceutical companies are allowed to deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations regarding the production, testing, and marketing of drugs. List of pharmaceutical companies; List of largest selling pharmaceutical products; List of largest pharmaceutical settlements
Drug Manufacturer Indication Adagrasib: In combination with cetuximab for the treatment of adults with KRAS G12C mutated locally advanced or metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy [2]